205 related articles for article (PubMed ID: 30530705)
1. The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
Buhl JL; Selt F; Hielscher T; Guiho R; Ecker J; Sahm F; Ridinger J; Riehl D; Usta D; Ismer B; Sommerkamp AC; Martinez-Barbera JP; Wefers AK; Remke M; Picard D; Pusch S; Gronych J; Oehme I; van Tilburg CM; Kool M; Kuhn D; Capper D; von Deimling A; Schuhmann MU; Herold-Mende C; Korshunov A; Brummer T; Pfister SM; Jones DTW; Witt O; Milde T
Clin Cancer Res; 2019 Mar; 25(6):1851-1866. PubMed ID: 30530705
[TBL] [Abstract][Full Text] [Related]
2. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
[TBL] [Abstract][Full Text] [Related]
3. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.
Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG
Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552
[TBL] [Abstract][Full Text] [Related]
4. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways.
Jones TA; Jeyapalan JN; Forshew T; Tatevossian RG; Lawson AR; Patel SN; Doctor GT; Mumin MA; Picker SR; Phipps KP; Michalski A; Jacques TS; Sheer D
Acta Neuropathol Commun; 2015 Dec; 3():86. PubMed ID: 26682910
[TBL] [Abstract][Full Text] [Related]
6. BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
Selt F; Sigaud R; Valinciute G; Sievers P; Zaman J; Alcon C; Schmid S; Peterziel H; Tsai JW; Guiho R; Martínez-Barbera JP; Pusch S; Deng J; Zhai Y; van Tilburg CM; Schuhman MU; El Damaty A; Bandopadhayay P; Herold-Mende C; von Deimling A; Pfister SM; Montero J; Capper D; Oehme I; Sahm F; Jones DTW; Witt O; Milde T
Neuro Oncol; 2023 Apr; 25(4):735-747. PubMed ID: 35977048
[TBL] [Abstract][Full Text] [Related]
7. Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
Selt F; El Damaty A; Schuhmann MU; Sigaud R; Ecker J; Sievers P; Kocher D; Herold-Mende C; Oehme I; von Deimling A; Pfister SM; Sahm F; Jones DTW; Witt O; Milde T
J Neurooncol; 2023 Dec; 165(3):467-478. PubMed ID: 37999877
[TBL] [Abstract][Full Text] [Related]
8. Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
Okamura K; Sato M; Suzuki T; Nohara K
Toxicol Appl Pharmacol; 2022 Nov; 454():116231. PubMed ID: 36089002
[TBL] [Abstract][Full Text] [Related]
9. Novel Surgical and Radiologic Risk Factors for Progression or Recurrence of Pediatric Pilocytic Astrocytoma.
Villanueva KG; Rea ND; Krieger MD
Pediatr Neurosurg; 2019; 54(6):375-385. PubMed ID: 31593969
[TBL] [Abstract][Full Text] [Related]
10. Suppression of p16 alleviates the senescence-associated secretory phenotype.
Buj R; Leon KE; Anguelov MA; Aird KM
Aging (Albany NY); 2021 Feb; 13(3):3290-3312. PubMed ID: 33550279
[TBL] [Abstract][Full Text] [Related]
11. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas.
Krieger MD; Gonzalez-Gomez I; Levy ML; McComb JG
Pediatr Neurosurg; 1997 Jul; 27(1):1-11. PubMed ID: 9486830
[TBL] [Abstract][Full Text] [Related]
13. A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
Acosta JC; Banito A; Wuestefeld T; Georgilis A; Janich P; Morton JP; Athineos D; Kang TW; Lasitschka F; Andrulis M; Pascual G; Morris KJ; Khan S; Jin H; Dharmalingam G; Snijders AP; Carroll T; Capper D; Pritchard C; Inman GJ; Longerich T; Sansom OJ; Benitah SA; Zender L; Gil J
Nat Cell Biol; 2013 Aug; 15(8):978-90. PubMed ID: 23770676
[TBL] [Abstract][Full Text] [Related]
14. MLL1 is essential for the senescence-associated secretory phenotype.
Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
[TBL] [Abstract][Full Text] [Related]
15. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
[TBL] [Abstract][Full Text] [Related]
16. Cerebral pilocytic astrocytoma.
Clark GB; Henry JM; McKeever PE
Cancer; 1985 Sep; 56(5):1128-33. PubMed ID: 4016701
[TBL] [Abstract][Full Text] [Related]
17.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
18. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
19. Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.
Mercurio S; Padovani L; Colin C; Carré M; Tchoghandjian A; Scavarda D; Lambert S; Baeza-Kallee N; Fernandez C; Chappé C; André N; Figarella-Branger D
Acta Neuropathol Commun; 2013 May; 1():17. PubMed ID: 24252689
[TBL] [Abstract][Full Text] [Related]
20. The protein kinase D1-mediated classical protein secretory pathway regulates the Ras oncogene-induced senescence response.
Su Y; Wang P; Shen H; Sun Z; Xu C; Li G; Tong T; Chen J
J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29420297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
